cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Inotiv Inc
1 own
4 watching
Current Price
$7.25
$0.12
(1.68%)
logo-notv
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
185.59M
52-Week High
52-Week High
42.63
52-Week Low
52-Week Low
3.645
Average Volume
Average Volume
0.33M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization185.59M
icon52-Week High42.63
icon52-Week Low3.645
iconAverage Volume0.33M
iconDividend Yield--
iconP/E Ratio--
What does the Inotiv Inc do?
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It has an agreement with BioVaxys to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
Read More
How much money does Inotiv Inc make?
News & Events about Inotiv Inc.
Zolmax
10days ago
Jefferies Financial Group lowered shares of Inotiv (NASDAQ:NOTV Get Rating) from a buy rating to a hold rating in a research report report published on Thursday, MarketBeat.com reports. Jefferies Financial Group currently has $8.00 price target on the stock. Jefferies Financial Group also issued ...
PR Newswire
11days ago
INOTIV INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inotiv, Inc. - NOTV INOTIV INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and...
Business Wire
25days ago
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Inotiv, Inc. (NasdaqCM: NOTV). On November 5, 2021, the Company completed its purchase of Envigo RMS, LLC...
PR Newswire
1month ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inotiv, Inc. - NOTV SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inotiv, Inc. - NOTV PR Newswire NEW YORK, Dec. 26, 2022 NEW YORK, Dec. 26, 2022 /PRNewswire/ --Pomerantz LLP is...
Globe Newswire
1month ago
NEW YORK, Dec. 25, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Inotiv, Inc. (Inotiv or the Company) (NASDAQ: NOTV). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns ...
Frequently Asked Questions
Frequently Asked Questions
What is Inotiv Inc share price today?
plus_minus_icon
Can Indians buy Inotiv Inc shares?
plus_minus_icon
How can I buy Inotiv Inc shares from India?
plus_minus_icon
Can Fractional shares of Inotiv Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Inotiv Inc stocks?
plus_minus_icon
What is today’s traded volume of Inotiv Inc?
plus_minus_icon
What is today’s market capitalisation of Inotiv Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Inotiv Inc?
plus_minus_icon
What percentage is Inotiv Inc down from its 52-Week High?
plus_minus_icon
What percentage is Inotiv Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$7.25
$0.12
(1.68%)
logo-notv
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00